See more : TC Biopharm (Holdings) Plc (TCBPW) Income Statement Analysis – Financial Results
Complete financial analysis of POSCO M-TECH Co., Ltd. (009520.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of POSCO M-TECH Co., Ltd., a leading company in the industry within the sector.
You may be interested
- OrganiGram Holdings Inc. (OGI) Income Statement Analysis – Financial Results
- Tesco PLC (TSCDY) Income Statement Analysis – Financial Results
- Greater Than AB (GREAT.ST) Income Statement Analysis – Financial Results
- Burnham Holdings, Inc. (BURCB) Income Statement Analysis – Financial Results
- Hi Gold Ocean Kmarin No.12 Ship Investment Company (172580.KS) Income Statement Analysis – Financial Results
POSCO M-TECH Co., Ltd. (009520.KQ)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 341.41B | 342.18B | 323.88B | 255.40B | 0.00 |
| Cost of Revenue | 322.16B | 322.61B | 296.19B | 233.92B | 0.00 |
| Gross Profit | 19.25B | 19.57B | 27.68B | 21.48B | 0.00 |
| Gross Profit Ratio | 5.64% | 5.72% | 8.55% | 8.41% | 0.00% |
| Research & Development | 70.45M | 26.40M | 112.09M | 25.57M | 0.00 |
| General & Administrative | 981.55M | 761.34M | 606.00M | 573.33M | 0.00 |
| Selling & Marketing | 3.14B | 2.78B | 2.46B | 2.04B | 0.00 |
| SG&A | 4.12B | 3.54B | 3.07B | 2.61B | 0.00 |
| Other Expenses | 10.57B | -358.71M | -108.55M | 568.69M | 0.00 |
| Operating Expenses | 14.76B | 13.21B | 11.31B | 9.60B | 0.00 |
| Cost & Expenses | 336.92B | 335.82B | 307.50B | 243.52B | 0.00 |
| Interest Income | 1.79B | 983.60M | 546.89M | 823.23M | 959.80M |
| Interest Expense | 36.98M | 45.78M | 8.25M | 12.58M | 9.23M |
| Depreciation & Amortization | 3.38B | 3.01B | 2.31B | 2.26B | 0.00 |
| EBITDA | 9.19B | 9.70B | 18.95B | 14.63B | 16.78B |
| EBITDA Ratio | 2.69% | 2.92% | 5.94% | 5.85% | 0.00% |
| Operating Income | 4.49B | 6.36B | 16.38B | 11.61B | 0.00 |
| Operating Income Ratio | 1.31% | 1.86% | 5.06% | 4.55% | 0.00% |
| Total Other Income/Expenses | 1.28B | 287.78M | 261.04M | 748.35M | 866.43M |
| Income Before Tax | 5.77B | 6.64B | 16.64B | 12.36B | 0.00 |
| Income Before Tax Ratio | 1.69% | 1.94% | 5.14% | 4.84% | 0.00% |
| Income Tax Expense | 900.41M | 1.82B | 3.57B | 2.95B | 0.00 |
| Net Income | 4.87B | 4.83B | 13.06B | 9.41B | 0.00 |
| Net Income Ratio | 1.43% | 1.41% | 4.03% | 3.68% | 0.00% |
| EPS | 117.00 | 116.00 | 314.00 | 226.00 | 254.00 |
| EPS Diluted | 117.00 | 116.00 | 314.00 | 226.00 | 254.00 |
| Weighted Avg Shares Out | 41.61M | 41.60M | 41.61M | 41.64M | 41.64M |
| Weighted Avg Shares Out (Dil) | 41.61M | 41.60M | 41.61M | 41.64M | 41.64M |
No news found for: 009520.KQ
Source: https://incomestatements.info
Category: Stock Reports